Vanderbilt University Medical center and the University of Zambia (UNZA) are partnering on a program to develop a cadre of researchers and educators to lead cancer epidemiology research and training in Zambia and to encourage U.S.-based researchers to engage in cancer research in low- and middle-income countries. In partnership with UNZA and the Zambia Cancer Diseases Hospital, the Vanderbilt […]
I’m excited as the new director of the Vanderbilt-Ingram Cancer Center to share with you some thoughts and updates. I have already experienced warm welcomes from so many of you in this new role, and it has reminded me how truly special our cancer center is. Thanks to all of you for making my transition […]
A new study in the New England Journal of Medicine highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit. The analysis, authored by Stacie Dusetzina, PhD, Ingram associate professor of Cancer Research and associate professor of Health Policy, […]
Major Players Daniel Beauchamp, MD, the John Clinton Foshee Distinguished Professor of Surgery, and Ethan Lee, MD, PhD, professor of Cell & Developmental Biology and Pharmacology: high-throughput screening to identify drug-like molecules, targeting the TGF-beta and WNT pathways Jordan Berlin, MD, co-director of the GI SPORE, interim director of the Division of Hematology and Oncology, […]
Abby Shields is the program manager for Affiliations and Research Advocacy at Vanderbilt-Ingram Cancer Center. Q: What do research advocates do? A: Our advocates are a group of cancer survivors and caregivers who work alongside our researchers to ensure the research conducted at VICC is timely, relevant and serves the needs of our catchment area. […]
